Topic
medications
60 stories related to this topic, newest first.
sbs.com.aufinance17 hrs ago
Health Secretary Directs Effort to Develop Guidance on Stopping Antidepressants
U.S. Health Secretary Robert F. Kennedy Jr. is moving ahead with plans for clinical guidance on stopping psychiatric medications. Federal officials met with mental health professionals earlier this month to review European approaches and non-drug options.
Abc Newsworld4 days ago
Earthquakes in Venezuela leave 3,811 dead and trigger rise in chronic illness and diarrhea
Twin earthquakes last month killed 3,811 people and damaged or destroyed more than 1,000 buildings. Relief services now report increased cases of skin conditions, diarrhea, and requests for chronic-disease medications.
world11 days ago
MassHealth Ends Medicaid Coverage of GLP-1 Drugs for Weight Loss
MassHealth will stop paying for GLP-1 medications prescribed solely for weight loss starting Friday. The change affects roughly 22,000 adults and 2,500 children enrolled in the state Medicaid program.
indiatoday.intoday.inworld11 days ago
Study Finds Cholesterol and Blood Pressure Levels Similar in Obese and Normal-Weight Adults Over 40
A study of nearly one million adults across seven countries found that cholesterol and blood pressure differences between people with obesity and those with normal BMI have narrowed or disappeared among those aged 40 and over. The convergence is attributed to greater use of stati…
world12 days ago
Medicare to Cover Weight-Loss Drugs at $50 Monthly Starting July 1
Beginning July 1, Medicare will extend coverage for weight-loss medications to millions of seniors at a capped out-of-pocket cost of $50 per month. The change marks the first time such drugs receive broad federal insurance support for this population.
freepressjournal.inscience12 days ago
Study Finds Women's Employment Rose 27% After GLP-1 Weight-Loss Drugs
A Harvard economics professor analyzed panel data and found that unemployed women who began GLP-1 medications saw a 27% rise in employment within roughly 18 months. Single women also showed higher rates of marriage or cohabitation, while self-reported life satisfaction remained u…
globalnews.capolitics13 days ago
Medicare Begins Temporary Coverage of GLP-1 Drugs for Obesity
A short-term pilot program allowing Medicare to cover GLP-1 medications for obesity treatment begins July 2 and runs through 2027. Beneficiaries will pay $50 monthly while manufacturers set a $245 price per drug. The program covers obesity treatment only and requires prior author…
cnbc.comfinance13 days ago
Medicare launches pilot offering GLP-1 obesity drugs for $50 monthly
A new Medicare pilot program will provide GLP-1 weight-loss medications to beneficiaries for $50 a month starting July 1. The initiative addresses prior cost barriers that kept these drugs out of reach for many seniors.
cnbc.comworld14 days ago
Medicare to Cover Select Weight-Loss Drugs for Two Years Starting July 2026 Under New Pilot
Some Medicare patients will access GLP-1 medications for weight loss through a new pilot program starting July 1 with a $50 monthly copay. The Medicare GLP-1 Bridge covers specific drugs from Eli Lilly and Novo Nordisk through December 2027. CBS News reported the details of eligi…
The Independentworld18 days ago
Novo Nordisk Seeks Wider Insurance Coverage for Weight-Loss Drugs
The company is pressing U.S. insurers to cover more of the cost of its GLP-1 medications. Direct consumer purchases now make up 30 percent of injectable sales and 90 percent of the new Wegovy pill.
The Hillscience22 days ago
Medicare to Offer $50 Monthly GLP-1 Access for Weight Management Starting July
A temporary demonstration program will let some Medicare Part D enrollees obtain GLP-1 medications for a flat $50 monthly copay from July 1, 2026, through December 31, 2027. The program operates outside standard Medicare coverage rules because federal law bars payment for weight-…
slowtwitch.comworld23 days ago
Athlete Publicizes GLP-1 Medication Use Ahead of Tennis Return
A 44-year-old professional tennis player returned to competition after nearly four years away and disclosed use of a GLP-1 weight-loss drug. The player won an opening doubles match at one tournament but lost the next. Sports officials are monitoring whether such medications affec…
Fox Newsscience23 days ago
GLP-1 weight-loss drugs show no hormone suppression in men, review finds
A systematic review of five trials presented at ENDO 2026 found GLP-1 medications did not lower male reproductive hormones. Some studies reported improvements in testosterone and sperm parameters among obese men.
nypost.comworld26 days ago
Study Links GLP-1 Drugs to Reduced Impulsivity
A new study suggests GLP-1 medications may affect decision-making beyond appetite control. Research examined links between these drugs and behavior in people taking them.
yahoo.comscience26 days ago
Study Finds GLP-1 Weight Loss Drug Users Reduced Daily Steps and Exercise
New research presented at a medical conference found adults using GLP-1 medications for weight loss decreased physical activity levels. Average daily steps fell and moderate-to-vigorous exercise minutes declined after starting treatment.
New York Postworld27 days ago
McGregor says he does not know what drugs he took during leg recovery
The mixed martial arts fighter addressed reports that he received performance-enhancing substances while recovering from a 2021 leg fracture. He stated he was unaware of the medications and criticized the former testing program.
New York Postworld27 days ago
Medicare to Offer GLP-1 Weight-Loss Drugs for $50 Monthly Starting July 1
Up to 14 million Medicare recipients who are overweight will be eligible for three GLP-1 medications at a $50 copay under a new pilot program. The Medicare GLP-1 Bridge runs from July 2026 through December 2027 and is separate from standard Part D coverage.
Statscience33 days ago
SAMHSA Cautions Against Long-Term Methadone and Buprenorphine Use While Trump Administration Explores Recovery-Focused Treatments and Alternatives
SAMHSA issued guidance in April 2026 cautioning against long-term use of the medications. Legislation introduced by Rep. Erin Houchin would reverse prior flexibilities for treatment access.
Statscience33 days ago
SAMHSA Letter Urges Medications for Opioid Addiction as Pathway to Recovery, Not Lifelong Use
The Substance Abuse and Mental Health Services Administration issued guidance in April cautioning against indefinite use of medications for opioid use disorder. The move follows earlier statements by Health Secretary Robert F. Kennedy Jr. endorsing those same treatments.
ABC Newsworld40 days ago
Observational Study Links GLP-1 Use to 30% Lower Breast Cancer Rate, but Researchers Caution Findings Are Not Definitive
A University of Pennsylvania analysis of health records found women taking GLP-1 medications had about 30 percent lower incidence of breast cancer. The observational study adds to research on weight-loss drugs and cancer prevention.
680news.comscience40 days ago
Cigna to Drop Wegovy and Zepbound Coverage for Employees as Oral Versions Launch at $149/Month
Cigna will stop covering GLP-1 weight loss drugs in its employee health plan starting July 1. Employees currently using the medications can switch to cash-pay options through manufacturers or TrumpRx.
New York Postscience41 days ago
Observational Study of 110,000 Women Finds Association Between GLP-1 Drug Use and 30% Lower Breast Cancer Risk
University of Pennsylvania researchers found women aged 45-80 taking GLP-1 medications had a 30% lower likelihood of developing breast cancer. The analysis examined records from more than 110,000 participants in the typical age range for diagnosis.
france24.comscience45 days ago
France to Reimburse Patients for Weight-Loss Drugs Starting Mid-June
French Health Minister Stéphanie Rist announced that France will begin reimbursing severely obese patients for two weight-loss medications from mid-June. The plan covers 65 percent of costs, with full coverage for most patients who have additional health conditions.
MarketWatchscience46 days ago
CVS to Cover Lilly GLP-1 Medications for Weight Management
CVS will add coverage for two GLP-1 medications produced by Eli Lilly. The decision expands access for millions of Americans seeking treatment for weight management.
New York Postscience46 days ago
Study Links GLP-1 Drugs to Lower Cancer Progression in Four Types
A Cleveland Clinic analysis of 12,112 patients found lower rates of progression to stage 4 disease among those taking GLP-1 medications compared with DPP-4 inhibitors. The observational results will be presented at the 2026 ASCO Annual Meeting.
ncbi.nlm.nih.govworld53 days ago
Studies Examine Weight-Loss Drugs and Cancer Outcomes
Recent research has examined whether medications such as Ozempic and Zepbound affect tumor progression and patient survival. The findings remain preliminary and require further study.
nypost.comworld53 days ago
Police Report Details Britney Spears' Medications and Statements Before DUI Arrest
A police report obtained by Page Six states that Britney Spears reported taking three prescription medications before her March 4 DUI arrest. The report also describes her statements about alcohol consumption and observations made by officers during the stop.
cnbc.compolitics54 days ago
Mark Cuban and President Trump Announce Expansion of TrumpRx Drug Site
Mark Cuban stood beside President Trump at the White House on Monday to announce the addition of more than 600 generic medications to the TrumpRx site through Cost Plus Drugs, Amazon Pharmacy, and GoodRx.
FO
New York Postpolitics56 days ago
TrumpRx Adds Over 600 Generic Drugs to Online Platform
President Trump announced the expansion of the federal drug-pricing site TrumpRx to include more than 600 generic medications. The platform now directs users to discounted options from several manufacturers and delivery services.
Statpolitics56 days ago
TrumpRx Adds Over 600 Generic Drugs Through Partnerships With Mark Cuban, Amazon, GoodRx
President Trump announced Monday that the TrumpRx platform now includes more than 600 generic medications through partnerships with Mark Cuban’s Cost Plus Drug Company, Amazon Pharmacy, and GoodRx. The expansion allows users to search for low-cost generics and compare prices at l…
world56 days ago
Former Guard Testifies Epstein Received Special Treatment at Federal Jail
A former corrections officer told House Oversight Committee members that Jeffrey Epstein received extra linens, a CPAP machine, and medications not available to other inmates. The testimony occurred amid renewed review of Epstein's 2019 death at the Metropolitan Corrections Cente…
AB
rediff.comscience56 days ago
Trump Administration Adds Over 600 Generic Drugs to TrumpRx Site
The White House expanded its direct-to-consumer drug platform on Monday by adding more than 600 generic medications. The move aims to increase options for cash-paying patients seeking lower prescription prices.
FI
New York Postpolitics56 days ago
Trump Announces Expansion of TrumpRx Platform Adding 600 Generic Drugs
President Trump unveiled an expansion of the TrumpRx drug-discount website at the White House on Monday. The platform now lists 600 generic medications and includes the Mark Cuban Cost Plus Drug Company as a partner.
politics60 days ago
Studies Find Modest Reductions in Migraine Drug Use and Asthma Exacerbations Among People Taking GLP-1RA Medications
Research presented at the European Congress on Obesity in Turkey found that Wegovy was associated with a 7 per cent reduction in triptan use among women with migraines and that GLP-1RA drugs correlated with a 26 per cent drop in asthma exacerbations. The studies drew on Danish he…
theconservativetreehouse.comworld62 days ago
Trump Administration Launches 18-Month Medicare Pilot Capping Copays at $50 for Certain GLP-1 Weight-Loss Drugs
President Donald Trump and the Centers for Medicare & Medicaid Services unveiled an 18-month pilot that will allow qualifying Medicare Part D beneficiaries to obtain certain GLP-1 medications such as Wegovy for $50 a month beginning July 1, 2026. The program marks a major policy…
news.sky.comscience62 days ago
STAT Launches Series Examining Alcohol-Related Deaths, Treatment Gaps and Policy Responses
STAT published an investigative series on May 12, 2026, detailing how alcohol kills more Americans than opioids, fentanyl, methamphetamines or heroin. Reporters Isabella Cueto and Lev Facher examined inconsistent screening, fragmented treatment and underused medications. The seri…
Statscience63 days ago
Medicare Spending on New Alzheimer’s Drugs Falls Below Projections
Medicare payments for recently approved Alzheimer’s medications are coming in well below earlier forecasts. A spokesperson for the Centers for Medicare and Medicaid Services said uptake of the drugs has been muted and the agency is not projecting significant spending in 2026 or 2…
upi.comscience63 days ago
Trump Administration Launches Moms.gov Website to Support Maternal Health and Fertility
The administration launched Moms.gov on May 11, 2026, as a centralized resource for new and expectant mothers. The site provides information on in vitro fertilization, prenatal and postnatal care, nutrition and links to discounted fertility medications. Officials also announced a…
foxnews.comscience63 days ago
Medicare Spending on Newly Approved Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous Alzheimer’s medications has been far lower than anticipated, prompting Medicare to forecast no significant spending on Leqembi and Kisunla in 2026 or 2027. Two years ago the program projected billions of dollars annually on Leqembi alon…
Statscience63 days ago
Medicare Spending on Alzheimer’s Drugs Leqembi and Kisunla Far Below Initial Projections
Uptake of the recently approved intravenous medications has been far lower than anticipated, prompting the Centers for Medicare and Medicaid Services to project no significant spending in 2026 or 2027. The muted adoption marks a sharp reversal from projections made two years ago.
The Sydney Morning Heraldworld65 days ago
Rebekah Beddoe attributes years of severe side effects and bipolar diagnosis to sertraline and subsequent psychiatric medications
Beddoe developed insomnia, akathisia and suicidal thoughts shortly after starting sertraline for post-natal exhaustion, leading to multiple additional prescriptions, a bipolar diagnosis and repeated psychiatric admissions. She later tapered off all drugs and regained her mental h…
manilatimes.networld66 days ago
Medicare to Test $50 Monthly Co-Pay for GLP-1 Weight Loss Drugs in New Pilot Program
The Centers for Medicare and Medicaid Services announced a two-year demonstration program that will allow certain enrollees to access FDA-approved GLP-1 medications for weight loss at a fixed $50 monthly co-pay with no deductible. The Medicare GLP-1 Bridge program runs from July…
AB
Substrate placeholder — needs reviewpolitics67 days ago
Naftali Bennett Files NIS 2 Million Defamation Lawsuit Over Psychiatric Medication Claims
Former Prime Minister Naftali Bennett filed a NIS 2 million defamation lawsuit against Environmental Protection Minister Idit Silman, MK Ohad Tal, and Channel 14. The suit concerns statements alleging that Bennett took psychiatric medications to function. Bennett stated the claim…
JE
manilatimes.netpolitics68 days ago
Made-in-China Agrees to Stop Selling GLP-1 Compounds in U.S., Pays $30,000 Penalty to Connecticut
The international online platform agreed to halt all sales of GLP-1 medications to U.S. customers and pay a suspended $300,000 penalty. Connecticut Attorney General William Tong said the drugs contained impurities and inconsistent active ingredients with no generic versions legal…
AB
abcnews.go.comworld68 days ago
Bipartisan Bill Would Require Written Consent for VA Psychiatric Drug Prescriptions
A coalition of 35 national veterans organizations sent a letter last month pressing House and Senate Veterans’ Affairs Committee leaders to prioritize legislation requiring written informed consent before the Department of Veterans Affairs prescribes psychiatric medications.
Nprscience68 days ago
Medicare to Test 18-Month GLP-1 Pilot for Weight Loss Drugs Starting July 2026
The Centers for Medicare & Medicaid Services will begin a short-term pilot on July 1, 2026, allowing eligible beneficiaries to obtain certain GLP-1 medications for weight loss at a flat $50 copayment. The 18-month program bridges to a potential longer-term initiative in 2028 afte…
The Federalistpolitics69 days ago
HHS Secretary Kennedy Unveils Initiative to Reduce Psychiatric Medication Use Through Deprescribing Incentives
Department of Health and Human Services Secretary Robert F. Kennedy, Jr. unveiled a new initiative to address overmedicalization in mental health care. The plan includes paying doctors for deprescribing medications and expanding non-pharmacologic treatments. Reforms will involve…
news18.comfinance70 days ago
French Regulator Fines Novo Nordisk and Eli Lilly Over Weight Loss Drug Ads
France's medicines regulator imposed fines on Novo Nordisk and Eli Lilly for misleading advertisements related to their weight loss drugs. The penalties come amid launches of oral GLP-1 medications in the U.S., with Novo Nordisk's Wegovy pill gaining early traction. Company execu…
swissinfo.chworld73 days ago
Medicine Shortages in England Impact Patients and Pharmacies
Patients in England are facing difficulties obtaining essential medications for conditions such as epilepsy, Parkinson's disease, and heart problems due to supply issues. Pharmacies are experiencing financial losses from rising global prices and reimbursement challenges. Governme…
prnewswire.comfinance74 days ago
Hershey Sees 8% Sales Rise for Ice Breakers Mints Amid GLP-1 Drug Trend
Hershey reported increased sales of its mints and gum in the first quarter of 2026, attributing the growth to the adoption of GLP-1 medications. CEO Kirk Tanner highlighted an 8% rise in Ice Breakers retail sales. Other companies like Lindt & Spruengli and Magnum Ice Cream also n…
medium.comworld79 days ago
Johnson & Johnson Adds Four Drugs to TrumpRx Discount Site Following Voluntary Agreement
Johnson & Johnson will begin marketing four medications on the Trump administration's TrumpRx website on Friday. The move follows a voluntary agreement announced in January that provides Medicaid access to affordable prescriptions in exchange for tariff exemptions. The addition m…
propublica.orgworld80 days ago
FDA Issues Priority Vouchers to Three Companies for Psychedelic Medication Reviews
The Food and Drug Administration announced on April 24, 2026, that it is issuing national priority vouchers to three companies to fast-track reviews of psychedelic medications. The companies are studying psilocybin for depression and methylone for PTSD. The move follows President…
AB
Substrate placeholder — needs reviewpolitics82 days ago
Mark Cuban Partners with TrumpRx Initiative to Lower Prescription Drug Costs
Billionaire investor Mark Cuban revealed a partnership with the Trump administration and TrumpRx to lower prescription drug costs. The initiative integrates Cost Plus Drugs' medications into TrumpRx. Cuban emphasized affordability across political lines in a Fox News appearance.
Substrate placeholder — needs reviewpolitics82 days ago
Urologists Report Rising Erectile Dysfunction Cases Among Younger Men
Medical experts have observed an increase in erectile dysfunction among men under 40, often linked to psychological factors. Reliance on prescription medications may exacerbate issues over time, potentially leading to more invasive treatments. Approaches combining low-dose medica…
Substrate placeholder — needs reviewworld89 days ago
Nature Health Study Analyzes Reddit Reports of Side Effects from GLP-1 Weight-Loss Drugs
An analysis in Nature Health examined Reddit posts from 70,000 users on GLP-1 medications like Ozempic and Mounjaro, revealing menstrual irregularities and temperature complaints not listed on labels. Nausea topped reported symptoms at 37 percent. Researchers noted these as signa…
Substrate placeholder — needs reviewscience91 days ago
JAMA Editorial Addresses AI Company Prescribing Renewal Medications in Utah
An editorial in the Journal of the American Medical Association discusses Doctronic, an AI company that prescribes renewal medications without physician involvement in Utah. The piece is titled 'The First AI Drug Prescriber.' It highlights the company's operations in the state.
ER
Substrate placeholder — needs reviewworld92 days ago
Hers Provides Online Services for Weight Loss, Hair Loss and Mental Health
Hers is a telehealth platform offering treatments for weight loss, hair loss and mental health. The services include GLP-1 medications, hair loss kits and mental health support. This article examines the costs and details of these offerings based on reporting from nypost.com.
Newsweekworld92 days ago
Options for Obtaining Uncovered Prescription Medications Under Health Insurance
Health insurance plans may not cover certain prescription medications, leaving individuals responsible for full costs. Options include discussing alternatives with health care professionals, requesting exceptions from insurers, and applying for assistance programs. These steps ca…
Substrate placeholder — needs reviewworld93 days ago
Medications Associated with Gynecomastia in Men
Gynecomastia, the enlargement of breast tissue in men, can occur due to natural hormone changes such as during puberty. Certain medications, including those for heart conditions and hair loss, have been linked to this condition. This article lists 10 such medications and provides…
The Boston Globeworld94 days ago
Reader Responses to GLP-1 Weight Loss Drugs and Insurance Coverage Changes
Readers of The Boston Globe have shared varied opinions on GLP-1 medications for obesity treatment following a February 22 article. Some highlight the drugs' benefits for health conditions beyond weight loss, while others question obesity as a disease and oppose insurance subsidi…